Nachrichten und Videos - DIPLOMAT PHARMACY INC.

The following statement is being issued by Robbins Geller Rudman & Dowd LLP regarding the Diplomat Pharmacy Securities Litigation: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION CHASE MORTIMER, Individually and on Behalf of All Others Similarly Situated, Plaintiff, vs. DIPLOMAT PHARMACY, INC., et al., Defendants. ) ) ) ) ) ) ) ) ) ) ) ) Case No. 1:19-cv-01735 (Consolidated) CLASS ACTION Honorable John F. Kness SUMMARY NOTICE TO: ALL PERSONS WHO PURCHASED DIPLOMAT...

SHAREHOLDER ALERT: WeissLaw LLP Investigates Diplomat Pharmacy, Inc. PR Newswire NEW YORK, Dec. 12, 2019 NEW YORK , Dec. 12, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Diplomat Pharmacy, Inc. ("Diplomat" or the "Company") (NYSE: DPLO) in connection with the proposed acquisition of the Company by UnitedHealth Group's (NYSE: UNH) OptumRx. Under the terms of the acquisition agreement, DPLO...

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of DIPLOMAT PHARMACY, INC - DPLO PR Newswire NEW YORK, Dec. 10, 2019 NEW YORK , Dec. 10, 2019 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City , is investigating Diplomat Pharmacy, Inc. ("Diplomat" or the "Company") (NYSE: DPLO) relating to the sale of the Company to UnitedHealth Group...

...

...

Diplomat Announces 3rd Quarter Financial Results; Updates 2019 Guidance 3rd Quarter Revenue of $1,301 Million, compared to $1,373 Million, Net Loss of $177 Million, compared to Net Income of $0.2 Million, Adjusted EBITDA of $11.5 Million, compared to $41.9 Million PR Newswire FLINT, Mich., Nov. 12, 2019 FLINT, Mich. , Nov. 12, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy and infusion services, announced financial...

Diplomat to Release Third-Quarter 2019 Operating Results Nov. 12 PR Newswire FLINT, Mich., Oct. 30, 2019 FLINT, Mich. , Oct. 30, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) will release its third-quarter 2019 operating results before market open Tuesday, Nov. 12 . A conference call and live webcast will be held at 8:30 a.m. ET . Shareholders and interested participants can listen to a live broadcast by calling 833.286.5805 (647.689.4450 for international callers) and entering...

Diplomat Announces Sale of Certain Assets of Envoy Health Management, LLC to Diligent Health Solutions, LLC The nation's largest independent provider of specialty pharmacy services sells certain assets to Diligent Health Solutions, LLC PR Newswire FLINT, Mich., Oct. 16, 2019 FLINT, Mich. , Oct. 16, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), effective today, has completed the sale of certain assets of Envoy Health Management, LLC to Diligent Health Solutions, LLC, a multifaceted...

Diplomat Announces Promotion of David Skomo to Chief Operating Officer of CastiaRx Following the retirement of Chris Luthin, David Skomo Appointed COO at CastiaRx. PR Newswire FLINT, Mich., Oct. 2, 2019 FLINT, Mich. , Oct. 2, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), has appointed David Skomo as chief operating officer of CastiaRx following the retirement of Chris Luthin . CastiaRx, a division of Diplomat, is a pharmacy benefit manager (PBM) that helps healthcare payers manage...

Diplomat Announces 2nd Quarter Financial Results; Updates 2019 Guidance 2nd Quarter Revenue of $1,288 Million, compared to $1,416 Million, Net Loss of $159.5 Million, compared to a Net Loss of $4.0 Million, Adjusted EBITDA of $19.3 Million, compared to $42.7 Million PR Newswire FLINT, Mich., Aug. 9, 2019 FLINT, Mich. , Aug. 9, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy and infusion services, announced financial...

Diplomat Announces Review of Strategic Alternatives PR Newswire FLINT, Mich., Aug. 9, 2019 FLINT, Mich. , Aug. 9, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) today announced that its Board of Directors is reviewing strategic alternatives. At the direction of its Board of Directors, the company is reviewing strategic alternatives focused on maximizing shareholder value. The strategic alternatives expected to be considered include, but are not limited to, a sale or merger of the...

Diplomat signs exclusive practice-based infusion agreement with Allergy Partners This innovative agreement forms the nation's first large-scale physician practice-based infusion program. PR Newswire FLINT, Mich., Aug. 8, 2019 FLINT, Mich. , Aug. 8, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), is pleased to announce an exclusive agreement between Diplomat and Allergy Partners, P.A., to manage in-office and in-home delivery and administration of infusion drugs and biologics. The...

Diplomat to Release Second-Quarter 2019 Operating Results August 9 PR Newswire FLINT, Mich., July 18, 2019 FLINT, Mich. , July 18, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), will release its second-quarter 2019 operating results before market open Friday, August 9 . A conference call and live webcast will be held at 8:30 a.m. ET . Shareholders and interested participants can listen to a live broadcast by calling 833.286.5805 (647.689.4450 for international callers) and entering...

(DPLO) Alert: Johnson Fistel, LLP Announces Investigation of Diplomat Pharmacy, Inc.; Long Term Investors Encouraged to Contact Firm PR Newswire SAN DIEGO, July 15, 2019 SAN DIEGO , July 15, 2019 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential violations of federal and state laws by Diplomat Pharmacy, Inc. ("Diplomat") (NYSE: DPLO) and certain of its officers. Earlier in 2019 a securities class action lawsuit was filed on behalf of purchasers of the...

Diplomat Launches Empower Ecosystem Patient Support Digital Library The nation's largest independent specialty pharmacy and infusion services provider launches a digital library of resources and tools for patients and caregivers. PR Newswire FLINT, Mich., July 9, 2019 FLINT, Mich. , July 9, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), announced the launch of EMPOWER ECOSYSTEM , an online collection of services and tools to help patients and caregivers manage the physical, social,...

Diplomat Announces 1st Quarter Financial Results 1st Quarter Revenue of $1,257 Million, compared to $1,342 Million, Net Loss of $14.3 Million, compared to a Net Loss of $0.5 Million, Adjusted EBITDA of $23.1 Million, compared to $39.6 Million PR Newswire FLINT, Mich., May 7, 2019 FLINT, Mich. , May 7, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy and infusion services, announced financial results for the quarter ended...

Diplomat Appoints Dave Loschinskey as Chief Operating Officer The company's board of directors has appointed Dave Loschinskey as chief operating officer effective May 2. PR Newswire FLINT, Mich., May 6, 2019 FLINT, Mich. , May 6, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), announced today that the company's board of directors has appointed Dave Loschinskey to serve as chief operating officer effective May 2. In addition, Gary Rice will retire from his position as executive vice...

Diplomat Using SMRxT Technology to Enhance Patient Care The nation's largest independent provider of specialty pharmacy and infusion services uses SMRxT Nomi® technology to enhance patient adherence and engagement. PR Newswire FLINT, Mich., April 25, 2019 FLINT, Mich. , April 25, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), is expanding its strategic relationship with medication adherence company SMRxT, creator of the Nomi ® system. Nomi sensor technologies record when a patient...

Diplomat to Release First-Quarter 2019 Operating Results May 7, Participate in Bank of America Merrill Lynch Healthcare Conference May 14 PR Newswire FLINT, Mich., April 17, 2019 FLINT, Mich. , April 17, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), will release its first-quarter 2019 operating results before market open Tuesday, May 7 . A conference call and live webcast will be held at 8:30 a.m. ET . Shareholders and interested participants can listen to a live broadcast by...

DPLO CLASS ACTION REMINDER: Hagens Berman Reminds Diplomat Pharmacy (DPLO) of Securities Class Action, Encourages Investors to Contact the Firm PR Newswire SAN FRANCISCO, April 15, 2019 SAN FRANCISCO , April 15, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP reminds investors in Diplomat Pharmacy, Inc. (NYSE: DPLO) of the pending securities class action and the April 25, 2019 Lead Plaintiff deadline. If you purchased or otherwise acquired Diplomat Pharmacy securities between February 26,...